Please login to the form below

The Opportunity for Women’s Health in Emerging Markets

Published in eyeforpharma April 2016 by Rachel Howard

In our latest article for eyeforpharma, Associate Director Rachel Howard looks at what we mean by "women's health" and outlines some of the considerations for pharma companies who want to maximize their opportunity in emerging markets. Gender roles, societal norms, culture, demographics, lifestyle and religion all have an impact on women’s health, so Howard advises that pharma start by building a full understanding of women in the markets in which they hope to successfully operate.

http://www.researchpartnership.com/news/2016/04/article-the-opportunity-for-women%E2%80%99s-health-i...


3rd June 2016

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Latest content on this profile

Rare diseases and orphan drugs: Our experience and expertise

Research Partnership
Conducting research for publication video

Research Partnership
Conference research case study
How conference research was used to gauge reactions to new clinical data and measure the impact of a company’s presence at a leading industry event
Research Partnership
Portfolio analysis: Using market research to master communications across a therapeutic category

Research Partnership
EphMRA round up 2018
EU Directors Angela Duffy, Richard Head and Dan coffin attended the EphMRA annual conference in Basel.
Research Partnership
Patients’willingness to pay
Considerations when developing an appropriate pricing strategy in self-pay markets
Research Partnership